TI
INSY

Trexquant Investment’s Insys Therapeutics, Inc. INSY Stock Holding History

Trexquant Investment’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,400
Closed -$495K – 1392
2015
Q3 		$495K Buy
+17,400
New +$640K 0.04% 726
2015
Q2 		– Sell
-11,000
Closed -$319K – 1357
2015
Q1 		$319K Sell
11,000
-15,200
-58% -$402K 0.03% 829
2014
Q4 		$552K Buy
+26,200
New +$518K 0.1% 423

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Trexquant Investment's INSY Position: Q4 2015 in Review

Trexquant Investment sold out of Insys Therapeutics, Inc. (INSY) in Q4 2015, closing a stake of 17,400 shares — an estimated $495K sold.

Trexquant Investment first reported a position in INSY in Q4 2014 and held it in 3 quarters. The position peaked at $552K in Q4 2014. 154 funds tracked by Wall St. Rank hold INSY as of Q4 2015.

  • Trexquant Investment reported no remaining Insys Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
  • Trexquant Investment sold 17,400 Insys Therapeutics, Inc. shares in Q4 2015, an estimated $495K.
  • Trexquant Investment first reported a position in Insys Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
  • Trexquant Investment's Insys Therapeutics, Inc. position peaked at $552K in Q4 2014.
  • 154 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2015.

Based on Trexquant Investment's 13F filing for Q4 2015, filed 10 Feb 2016.